These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32282176)

  • 21. Methods of cost-effectiveness analysis in the evaluation of new antipsychotics: implications for schizophrenia treatment.
    Neumann PJ
    J Clin Psychiatry; 1999; 60 Suppl 3():9-14; discussion 15. PubMed ID: 10073371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of olanzapine long-acting injection in the treatment of patients with schizophrenia in the United States: a micro-simulation economic decision model.
    Furiak NM; Ascher-Svanum H; Klein RW; Smolen LJ; Lawson AH; Montgomery W; Conley RR
    Curr Med Res Opin; 2011 Apr; 27(4):713-30. PubMed ID: 21265593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA.
    Edwards NC; Locklear JC; Rupnow MF; Diamond RJ
    Pharmacoeconomics; 2005; 23 Suppl 1():75-89. PubMed ID: 16416763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An economic review of compliance with medication therapy in the treatment of schizophrenia.
    Thieda P; Beard S; Richter A; Kane J
    Psychiatr Serv; 2003 Apr; 54(4):508-16. PubMed ID: 12663838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managed care aspects of psoriasis and psoriatic arthritis.
    Evans C
    Am J Manag Care; 2016 Jun; 22(8 Suppl):s238-43. PubMed ID: 27356195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical antipsychotics in the managed care era.
    Loebel AD; Botts SR; Feldman BI
    Am J Manag Care; 1998 Jan; 4 Suppl():S37-50; quiz S51-2. PubMed ID: 10181074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of medical and economic benefits of antipsychotics in the treatment of schizophrenia in France].
    Druais S; Doutriaux A; Cognet M; Godet A; Lançon C; Levy P; Samalin L; Guillon P
    Encephale; 2017 Aug; 43(4):311-320. PubMed ID: 27623123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The economic impact of schizophrenia.
    Rice DP
    J Clin Psychiatry; 1999; 60 Suppl 1():4-6; discussion 28-30. PubMed ID: 10037163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The functionality and economic costs of outpatients with schizophrenia in Taiwan.
    Lee IH; Chen PS; Yang YK; Liao YC; Lee YD; Yeh TL; Yeh LL; Cheng SH; Chu CL
    Psychiatry Res; 2008 Apr; 158(3):306-15. PubMed ID: 18243334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia : a 12- and 24-month follow-up from the e-STAR database in Spain.
    Olivares JM; Rodriguez-Martinez A; Burón JA; Alonso-Escolano D; Rodriguez-Morales A;
    Appl Health Econ Health Policy; 2008; 6(1):41-53. PubMed ID: 18774869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia.
    Ascher-Svanum H; Zhu B; Faries D; Lacro JP; Dolder CR
    J Clin Psychiatry; 2006 Jul; 67(7):1114-23. PubMed ID: 16889456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Economic Burden of Schizophrenia in the United States in 2013.
    Cloutier M; Aigbogun MS; Guerin A; Nitulescu R; Ramanakumar AV; Kamat SA; DeLucia M; Duffy R; Legacy SN; Henderson C; Francois C; Wu E
    J Clin Psychiatry; 2016 Jun; 77(6):764-71. PubMed ID: 27135986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic cost and quality of life of family caregivers of schizophrenic patients attending psychiatric hospitals in Ghana.
    Opoku-Boateng YN; Kretchy IA; Aryeetey GC; Dwomoh D; Decker S; Agyemang SA; Tozan Y; Aikins M; Nonvignon J
    BMC Health Serv Res; 2017 Dec; 17(Suppl 2):697. PubMed ID: 29219074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The humanistic and economic burden of providing care for a patient with schizophrenia.
    Csoboth C; Witt EA; Villa KF; O'Gorman C
    Int J Soc Psychiatry; 2015 Dec; 61(8):754-61. PubMed ID: 25823542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving adherence to antipsychotic pharmacotherapy.
    Masand PS; Narasimhan M
    Curr Clin Pharmacol; 2006 Jan; 1(1):47-56. PubMed ID: 18666377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Advocacy for the establishment of a comprehensive strategy to reduce the "burden" of schizophrenic disorders].
    Leguay D
    Encephale; 2016 Oct; 42(5):476-483. PubMed ID: 27623121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics.
    Pilon D; Tandon N; Lafeuille MH; Kamstra R; Emond B; Lefebvre P; Joshi K
    Clin Ther; 2017 Oct; 39(10):1972-1985.e2. PubMed ID: 28919292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial.
    Rosenheck R; Perlick D; Bingham S; Liu-Mares W; Collins J; Warren S; Leslie D; Allan E; Campbell EC; Caroff S; Corwin J; Davis L; Douyon R; Dunn L; Evans D; Frecska E; Grabowski J; Graeber D; Herz L; Kwon K; Lawson W; Mena F; Sheikh J; Smelson D; Smith-Gamble V;
    JAMA; 2003 Nov; 290(20):2693-702. PubMed ID: 14645311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antipsychotic therapy: a pharmacoeconomic perspective.
    Rey JA
    Am J Health Syst Pharm; 2002 Nov; 59(22 Suppl 8):S5-9. PubMed ID: 12455293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.